-Adjuvant systemic therapy of breast carcinoma-.
Goldhirsch
A
A
Schweizerische Arbeitsgruppe für Klinische Krebsforschung (SAKK), Servizio Oncologico Cantonale, Ospedale Civico, Lugano, Switzerland.
Castiglione-Gertsch
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D010052:Ovariectomy; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate; D016896:Treatment Outcome